In the fourth quarter, Pfizer said its two-shot coronavirus vaccine, Comirnaty, brought in more than USD 12.5 billion in revenue, which helped the company’s total top line double compared to the last quarter of 2020.In the fourth quarter, Pfizer said its two-shot coronavirus vaccine, Comirnaty, brought in more than USD 12.5 billion in revenue, which helped the company’s total top line double compared to the last quarter of 2020.Read More
